Benfotiamine
Names
[ CAS No. ]:
22457-89-2
[ Name ]:
Benfotiamine
[Synonym ]:
berdi
S-benzoylthiamine monophosphate
bietamine
biotamin
S-[(2Z)-2-{[(4-Amino-2-methyl-5-pyrimidinyl)methyl](formyl)amino}-5-(phosphonooxy)-2-penten-3-yl] benzenecarbothioate
betivina
S-Benzoyl-thiamin-monophosphat
EINECS 245-013-4
Benfotiamine
neurostop
S-Benzoylthiamine O-Monophosphate
8088c.b.
Benfotiaminum
S-Benzoyl-thiamin-O-monophosphat
S-benzoylthiamine-O-monophosphate
MFCD00057343
MilgaMMa
btmp
benzenecarbothioic acid, S-[(1Z)-2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl]formylamino]-1-[2-(phosphonooxy)ethyl]-1-propen-1-yl] ester
nitanevril
tabiomyl
Biological Activity
[Description]:
[Related Catalog]:
[References]
[6]. Benfotiamine
[Related Small Molecules]
Chemical & Physical Properties
[ Density]:
1.4±0.1 g/cm3
[ Boiling Point ]:
745.1±70.0 °C at 760 mmHg
[ Melting Point ]:
165ºC
[ Molecular Formula ]:
C19H23N4O6PS
[ Molecular Weight ]:
466.448
[ Flash Point ]:
404.4±35.7 °C
[ Exact Mass ]:
466.107605
[ PSA ]:
191.05000
[ LogP ]:
1.81
[ Vapour Pressure ]:
0.0±2.6 mmHg at 25°C
[ Index of Refraction ]:
1.645
[ Storage condition ]:
2-8°C
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- DH6910000
- CHEMICAL NAME :
- Benzoic acid, thio-, S-ester with N-((4-amino-2-methyl-5-pyrimidinyl)methyl)-N-(4-hydro xy- 2-mercapto-1-methyl-1-butenyl)formamide dihydrogen phosphate (ester)
- CAS REGISTRY NUMBER :
- 22457-89-2
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C19-H23-N4-O6-P-S
- MOLECULAR WEIGHT :
- 466.49
- WISWESSER LINE NOTATION :
- T6N CNJ B1 DZ E1VMY1&UYSVR&2OPQQO
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 15 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,781,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 2200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- 85IPAE "Modern Pharmaceuticals of Japan, III," Tokyo, Japan Pharmaceutical, Medical and Dental Supply Exporters' Assoc., 1968 Volume(issue)/page/year: -,78,1968
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xn
[ Risk Phrases ]:
R20/21/22
[ Safety Phrases ]:
26-36
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
2
[ RTECS ]:
DH6910000
Articles
BMC Pharmacol. 8 , 10, (2008)
Lipid-soluble thiamine precursors have a much higher bioavailability than genuine thiamine and therefore are more suitable for therapeutic purposes. Benfotiamine (S-benzoylthiamine O-monophosphate), a...
The detrimental effects of acute hyperglycemia on myocardial glucose uptake.Life Sci. 105(1-2) , 31-42, (2014)
Although acute hyperglycemic (AHG) episodes are linked to lower glucose uptake, underlying mechanisms remain unclear. We hypothesized that AHG triggers reactive oxygen species (ROS) production and inc...
The effect of benfotiamine on mu-opioid receptor mediated antinociception in experimental diabetes.Exp. Clin. Endocrinol. Diabetes 122(3) , 173-8, (2014)
Diabetic neuropathy is a prevalent, disabling disorder. Currently, the only treatments available to patients with diabetic neuropathy are glucose control and pain management. B vitamin present neuropr...